Rapidly progressive glomerulonephritis epidemiology and demographics
|
Rapidly progressive glomerulonephritis Microchapters |
|
Differentiating Rapidly progressive glomerulonephritis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Rapidly progressive glomerulonephritis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Rapidly progressive glomerulonephritis epidemiology and demographics |
|
FDA on Rapidly progressive glomerulonephritis epidemiology and demographics |
|
CDC on Rapidly progressive glomerulonephritis epidemiology and demographics |
|
Rapidly progressive glomerulonephritis epidemiology and demographics in the news |
|
Blogs on Rapidly progressive glomerulonephritis epidemiology and demographics |
|
Directions to Hospitals Treating Rapidly progressive glomerulonephritis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2] Jogeet Singh Sekhon, M.D. [3]
Overview
The incidence of RPGN is 1 per 1 million individuals per year and the incidence is affected by race and age.
Epidemiology and demographics
Incidence
- The incidence of rapidly progressive glomerulonephritis is around 1 per million individuals per year.[1] [2]
Prevalance
- The prevalence of rapidly progressive glomerulonephritis increases with age.
Race
- Rapidly progressive glomerulonephritis is more prevalent in the white race more than the black race.
Gender
- Men and women are affected equally by rapidly progressive glomerulonephritis.
Age
- It is more common in old individuals.
References
- ↑ Cui Z, Zhao MH (2011). "Advances in human antiglomerular basement membrane disease". Nat Rev Nephrol. 7 (12): 697–705. doi:10.1038/nrneph.2011.89. PMID 21769105.
- ↑ Hedger N, Stevens J, Drey N, Walker S, Roderick P (2000). "Incidence and outcome of pauci-immune rapidly progressive glomerulonephritis in Wessex, UK: a 10-year retrospective study". Nephrol Dial Transplant. 15 (10): 1593–9. PMID 11007827.